Solara Active Pharma Sciences Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SOLARA.NS | INDSWFTLAB.BO | SPARC.NS | THEMISMED.NS | RPGLIFE.NS | 300485.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 31.04B | 31.50B | 63.66B | 9.44B | 42.93B | 3.85B |
| P/E (TTM) | 83.4 | 37.0 | 3.9 | 23.5 | 38.7 | — |
| Forward P/E | 20.5 | — | 3.5 | — | 27.6 | — |
| Price/book | 2.2 | 2.1 | 4.8 | 2.4 | 7.1 | 1.2 |
| Dividend yield | — | — | — | 0.50% | 0.92% | 0.38% |
| 1-year change | +14.61% | +268.15% | +37.71% | −15.87% | +6.05% | −36.24% |
| Today | −0.25% | −4.09% | +5.84% | +2.13% | −0.11% | +2.17% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All SOLARA.NS news ›Solara Active Pharma Sciences Ltd Reports ₹28.46 Crore Consolidated Profit In Q2
Mumbai: Solara Active Pharma Sciences Ltd on Friday reported a consolidated net profit after tax of ₹28.46 crore for the quarter ended 30 September 2026, compared to a net loss of ₹10.10 crore in the corresponding quarter of the previous…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- freepressjournal.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.